• This record comes from PubMed

Endometriosis and gynaecological cancers: molecular insights behind a complex machinery

. 2021 Dec ; 20 (4) : 201-206. [epub] 20211206

Status PubMed-not-MEDLINE Language English Country Poland Media print-electronic

Document type Journal Article, Review

Endometriosis is described as the presence of both endometrial glandular and stromal cells outside the uterine cavity. A major characterization of this disease is ectopic implantation of endometrial cells with increased migration. It is one of the leading causes of morbidity among premenopausal women, with a prevalence of 10-16% of women of reproductive age. Despite over century of intensive research, none of the current treatment options represents a real cure. Based on the current knowledge, endometriosis, particularly its atypical version, is considered to be a transitional form from benign disease to tumour. However, the exact mechanisms of this conversion are still not fully established.

See more in PubMed

Kralickova M, Vetvicka V, Fiala L, et al. . The search for biomarkers in endometriosis: a long and windy road. Reprod Sci 2021. PubMed

Kajihira H, Yamada Y, Kanayama S, et al. . New insight into the pathology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol 2011; 2: 73-79. PubMed

Szamatowicz M, Hermanowicz-Szamatowicz K. Endometriosis–a decade later–still an enigmatic disease. What is the new in the diagnosis and treatment? Oncol Endocrinol 2020; 36: 104-108. PubMed

Lagana AS, Garzon S, Gotte M, et al. . The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 2019; 20: 5615. PubMed PMC

Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925; 10: 1-72.

Scott RB. Malignant change in endometriosis. Obstet Gynecol 1953; 2: 283-289. PubMed

Kralickova M, Vetvicka V, Lagana AS. Endometrial cancer–is our knowledge changing? Transl Cancer Res 2020; 9: 7734-7745. PubMed PMC

Pearce CL, Templeman C, Rossing MA, et al. . Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385-394. PubMed PMC

Levin G, Cheng C, Healey M, et al. . Endometriosis–it is not just beginning. J Gynecol Obste Human Reprod 2020; 49: 101744. PubMed

Olovsson M. Immunological aspects of endometriosis: An update. Am J Reprod Immunol 2011; 66 (Suppl.1): 101-114. PubMed

Vlahos NF, Kalampokas T, Fotiou S. Endometriosis and ovarian cancer. A review. Gynecol Endocrin 2010: 26: 213-219. PubMed

Hunn, J, Rodriquez, GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 2012; 1: 3-23. PubMed

Ralaitzopoulos DR, Mitsopoulou A, Illiopoulou SM, et al. . Association between endometriosis and gynecological cancers: a critical review of the literature. Arch Gynecol Obstetr 2020; 301: 355-367. PubMed

Ota Y, Ota K, Takahashi T, et al. . Primary endometrioid carcinoma of the uterosacral ligament arising from deep infiltrating endometriosis 6 years after bilateral salphingo-oophorectomy due to atypical proliferative endometrioid tumor of the ovary: a rare case report. World J Surg Oncol 2020; 18: 329. PubMed PMC

Pan Q, Luo X, Toloubeydokhti T, et al. . The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007; 13: 797-806. PubMed

Nakamura N, Terai Y, Nunode M, et al. . The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer. J Ovar Canc 2020; 13: 51. PubMed PMC

Suryawanshi S, Vlad AM, Lin HM, et al. . Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013; 19: 1213-1224. PubMed PMC

Wu RL, Ali S, Bandyopadhyay S, et al. . Comparative analysis of differentially expressed miRNAs and their downstream mRNAs in ovarian cancer and its associated endometriosis. J Cancer Sci Ther 2015; 7: 258-265. PubMed PMC

Kralickova M, Vetvicka V. Endometriosis and ovarian cancer. World J Clin Oncol 2014; 5: 800-805. PubMed PMC

Gadducci A, Zannoni GF. Endometriosis-associated extraovarian malignancies: a challenging question for the clinician and the pathologist. Anticancer Res 2020; 40: 2429-2438. PubMed

Hermens M, van Altena AM, van der Aa M, et al. . Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 women. Am J Obst Gynecol 2021; 224: 284.e1-284.e10. PubMed

Hermens M, van Altena AM, Niebort TE, et al. . Incidence of endometroid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study. Am J Obstet Gynecol 2020; 223: 107.e1-11. PubMed

Buis CC, van Leeuwen FE, Mooiji TM, et al. . OMEGA Project Group. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 2013; 28: 3358-3369. PubMed

Pearce CL, Templeman C, Rossing MA, et al. . Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385-394. PubMed PMC

Dzatic-Smiljkovic O, Vasiljevic M, Djukic M, et al. . Frequency of ovarian endometriosis in epithelial ovarian cancer patients. Clin Exp Obstet Gynecol 2011; 38: 394-398. PubMed

La Grenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19: 1080-1084. PubMed

Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91: 1459-1467. PubMed

Wang C, Liang Z, Liu X, et al. . The association between endometriosis, tubal ligation, hysterectomy and epithelial ovarian cancer: meta-analyses. Int J Environ Res Public Health 2016; 13: 1138. PubMed PMC

Kobayashi H. Potential scenarios leading to ovarian cancer arising from endometriosis. Redox Rep 2016; 21: 119-126. PubMed PMC

Murakami K, Kotani Y, Nakai H, et al. . Endometriosis-associated ovarian cancer: the origin and targeted therapy. Cancers 2020; 12: 1676. PubMed PMC

Brinton LA, Sakoda LC, Sherman ME, et al. . Relatioship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarker Prev 2005; 14: 2929-2935. PubMed

Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gyn 2011; 2011: 140310. PubMed PMC

Kondi-Pafiti A, Papakonstantinou E, Iavazzo C, et al. . Clinicopathological characteristics of ovarian carcinomas associated with endometriosis. Arch Gynecol Obstet 2012; 285: 479-483. PubMed

Pejovic T, Thisted S, White M, et al. . Endometriosis and endometriosis-associated ovarian cancer (EAOC). Adv Exp Med Biol 2020; 1242: 73-87. PubMed

Wei JJ, William J, Bulun S. Endometriosis and ovarian cancer: a review of clinical, pathologi, and molecular aspects. Int J Gynecol Pathol 2011; 20: 553-568. PubMed PMC

Kumar S, Munkarah A, Arabi H, et al. . Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol 2011; 204: 63.e1. PubMed

Kok VC, Tsai HJ, Su CF, et al. . The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. Int J Gynecol Cancer 2015; 25: 968-976. PubMed

Chiang AJ, Chang C, Huang CH, et al. . Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data. J Gynecol Oncol 2018; 29: e28. PubMed PMC

Eoh KJ, Han M, Kim EH, et al. . Markedly increased risk of malignancies in women with endometriosis. Gynecol Oncol 2021; 161: 291-296. PubMed

Bertelsen L, Mellemkjaer L, Frederiksen K, et al. . Risk for breast cancer among women with endometriosis. Int J Cancer 2007; 120: 1372-1375. PubMed

Lu J, Tao X, Zhou J, et al. . Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis. Oncotarget 2017; 8: 5843-5852. PubMed PMC

Koiyama S, Aoki D, Tominagha E, et al. . Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis. Clinicopathologic evaluation. Gynecol Oncol 1999; 72: 342-346. PubMed

Noli S, Cipriani S, Scarfone G, Villa A, et al. . Long term survival of ovarian endometriosis associated clear cell and endometriod ovarian cancers. Int J Gynecol Canc 2013; 23: 244-248. PubMed

Bounous VE, Ferrero A, Fuso L, et al. . Endometriosis-associated ovarian cancer: a distinct clinical entity? Anticancer Res 2016; 36: 3445-3449. PubMed

Shin HY, Yang W, Chay DB, et al. . Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma. Mol Oncol 2021; 15: 987. PubMed PMC

Wilbur MA, Shih IM, Segars JH, et al. . Cancer implications for patients with endometriosis. Semin Reprod Med 2017; 35: 110-116. PubMed

Wiegand KC, Shah SP, Al-Agha OM, et al. . ARID1A mutations in endometriosis-associated ovarian carcinomas. N Eng J Med 2010; 363: 1532-1543. PubMed PMC

Bhyan SB, Zhao L, Wee YK, et al. . Genetic links between endometriosis and cancer in women. Peer J 2019; 7: e8135. PubMed PMC

Jonusiene V, Sasnauskiene A. Notch and endometrial cancer. Exp Med Biol 2021; 1287: 47-57. PubMed

Kobayashi H. Potential scenarios leading to ovarian cancer arising from endometriosis. Redox Rep 2016; 21: 119-126. PubMed PMC

Fontana J, Zima M, Vetvicka V. Biological markers of oxidative stress in cardiovascular diseases: after so many studies, what do we know? Immunol Invest 2018; 47: 823-843. PubMed

Huang CY, Cheng NM, Wang, PH. Risk factors associated with epithelial ovarian cancer in women with endometriosis. Taiwanese J Obstet Gynecol 2020; 59: 353-355. PubMed

Kralickova M, Vetvicka V. Immunological aspects of endometriosis: a review. Ann Transl Med 2015; 3: 153. PubMed PMC

Vogel TJ, Knickerbocker A, Shah CA, et al. . An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. J Gynecol Oncol 2015; 26: 25-31. PubMed PMC

Cintesun FNI, Kerumoglu OS, Cintesun E, et al. . The relation between KRAS LCS6 polymorphism and endometrium cancer. J Obstet Gynecol 2020; 40: 988-993. PubMed

Konno T, Kohno T, Okada T, et al. . ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer. Histochem Cell Biol 2020; 154: 197-213. PubMed

Kobayashi H. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol 2009; 14: 378-382. PubMed

Van Leeuwen FE, Klip H, Mooij TM, et al. . Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Human Reprod 2011; 16: 3456-3465 . PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...